LONIGUTAMAB UGODOTIN
UNII VJ9X8A8CJ5

Substance Identification & Data

This profile provides standardized clinical and technical data for Lonigutamab Ugodotin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) VJ9X8A8CJ5.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2363754-30-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
VJ9X8A8CJ5
CAS Registry Number
2363754-30-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
LONIGUTAMAB UGODOTIN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C179101
National Cancer Institute reference terminology for clinical and research data.
INN ID
11640
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lonigutamab Ugodotin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LONIGUTAMAB UGODOTIN

Common Names & Synonyms

IMMUNOGLOBULIN G1 (DE-C-TERMINAL-LYSINE), ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL HZ-208F2-4 .GAMMA.1-CHAIN), COMPLEX WITH HUMAN-MUS MUSCULUS MONOCLONAL HZ-208F2-4 .KAPPA.-CHAIN, DIMER, TETRAKIS(THIOETHER) WITH N-(2-(4-((6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)METHYLAMINO)PHENYL)ETHYL)-N-METHYL-L-VALYL-L-VALYL-(3R,4S,5S)-3-METHOXY-5-METHYL-4-(METHYLAMINO)HEPTANOYL-(.ALPHA.R,.BETA.R,2S)-.BETA.-METHOXY-.ALPHA.-METHYL-2-PYRROLIDINEPROPANOYL-L-PHENYLALANINE
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IGF1R (INSULIN LIKE GROWTH FACTOR 1 RECEPTOR, IGF1-R, IGF-1R, CD221)), HUMANIZED MONOCLONAL ANTIBODY CONJUGATED TO A DOLASTATIN DERIVATIVE (UGODOTIN GROUPS)
LONIGUTAMAB UGODOTIN [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus